Clinical Study
Evaluation of Ferric and Ferrous Iron Therapies in Women with Iron Deficiency Anaemia
Table 3
Pre- and posttreatment laboratory values between the groups.
| Parameter | Fe+3 group | Fe+2 group | |
| Hg (g/dL) | 0.95 ± 0.74 | 2.25 ± 0.94 | S | Htc (%) | 2.62 ± 2.07 | 5.9 ± 2.3 | S | RBC (1012/L) | 0.24 ± 0.14 | 0.32 ± 0.33 | NS | Ferritin (ng/dL) | 4.13 ± 7.5 | 4.05 ± 10.2 | NS | TIBC | 19.5 ± 53.3 | 36.8 ± 71.9 | S |
|
|